KCNQ1 and short QT syndrome type 2: Inhibition of IKs as a potential therapeutic strategy was further tested in another form of SQT2 caused by the KCNQ1 V141M mutation, which differs from the V307L mutation in that it induces a constitutively active voltage-independent current component11.